Skip to content

Surgical Site Infection in Perforated Appendicitis After Peritoneal Lavage With Super-oxidised Solution

Incidence of Surgical Site Infection in Perforated Appendicitis After Peritoneal Lavage With Super-oxidised Solution: A Randomised Double-blind, Placebo-controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04512196
Acronym
PLaSSo
Enrollment
102
Registered
2020-08-13
Start date
2020-09-09
Completion date
2022-04-11
Last updated
2022-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perforated Appendicitis

Keywords

Perforated Appendicitis, Super-oxidised solution, Surgical site infection, Peritoneal lavage

Brief summary

This study is to evaluate the effectiveness of peritoneal lavage with super-oxidised solution in reducing surgical site infection after open surgery for perforated appendicitis.

Detailed description

Open appendicectomy for perforated appendicitis is associated with significant morbidity from surgical site infection. The standard practice is to perform peritoneal and wound lavage using normal saline solution. The investigators propose the use of superoxidized solution for peritoneal and wound lavage to decrease the incidence of surgical site infection. Superoxidized solutions contain hypochlorous acid (HOCl) which has bactericidal properties. The reactive oxygen species that is produces damages cell wall membrane of unicellular organisms, however remains safe when in contact with human or animal tissue. It is commonly used for topical treatment of wounds.

Interventions

DRUGSuperoxidized Water

Super-oxidized solution contains hypochlorous acid (HOCl) which exhibits bactericidal activity. These reactive species create an imbalanced osmotic gradient which damages the cell membrane integrity of single celled organisms, and subsequently denaturing its lipid and protein content. Multicellular organisms including host tissue are not susceptible to such changes in osmolarity hence spared from damage.

DRUGNormal Saline

Normal saline contains 0.9% sodium chloride.

Sponsors

Ministry of Health, Malaysia
CollaboratorOTHER_GOV
Hospital Queen Elizabeth, Malaysia
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The study participants, healthcare providers who attend to the participants during the trial (surgeon and nurses), outcome evaluators (surgical doctors and nurses) and data collectors will be blinded to the allocation. The sterile study solution (super-oxidised solution) or placebo (normal saline 0.9%) will be stored in a similar storage container and will have the same clear appearance.

Intervention model description

Randomised double-blind placebo-controlled parallel-group study. This is a superiority study assessing the effectiveness of the intervention

Eligibility

Sex/Gender
ALL
Age
13 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Patients between the age 13 and 70 years 2. Diagnosed with perforated appendicitis intra-operatively 3. Undergo open appendicectomy via Lanz incision

Exclusion criteria

1. Surgical technique: Laparoscopic appendicectomy or mid-line laparotomy 2. Patients on steroid treatment and immunosuppressant therapy.

Design outcomes

Primary

MeasureTime frameDescription
Surgical site infection30 days post surgeryNumber of participants with surgical site infection after open surgery for perforated appendicitis

Secondary

MeasureTime frameDescription
Inflammatory marker C-reactive protein24 and 48 hours post surgeryChange in serum inflammatory marker C-reactive protein level after open surgery for perforated appendicitis
Post-operative IleusFrom end of surgery till first passage of flatus or bowel opening, whichever comes first, assessed up to 30 daysDuration of post-operative ileus after open surgery for perforated appendicitis

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026